Ortal Ben Aharon

• Envato Pty Ltd in its $285 million acquisition by Shutterstock, Inc.
• Renesas Electronics Corporation in its $345 million acquisition of Transphorm, Inc.
• ImmuNext, Inc. in its agreement with Royalty Pharma plc in which Royalty Pharma will acquire interest in ImmuNext’s Frexalimab for approximately $525 million
• EQRx, Inc. in its $1.1 billion acquisition by Revolution Medicines  
• Marlin Equity Partners in its acquisition of Meltwater
• iRobot Corporation in its proposed acquisition by Amazon.com, Inc. for approximately $1.7 billion
• Thoma Bravo in its acquisition of Nearmap for AUD $1.055 billion
• KVH Industries in its sale of Inertial Navigation segment asset to EMCORE for $55 million
• CenExel Clinical Research in its acquisition of Apex Innovative Sciences
• Payspan in its sale to Zelis
• OpenEye in its $500 million sale to Cadence Design Systems
• Frazier Healthcare Partners in its sale of Parata Systems to Becton Dickinson & Co. for $1.525 billion
• CSafe Global, a portfolio company of Frazier Healthcare Partners and Thomas H. Lee Partners, in its acquisition of Softbox Systems
• OneLogin in its acquisition by One Identity LLC, a subsidiary of Quest Software Inc.
• Datavant in its merger with CIOX Health for $7 billion
• TaxJar in its acquisition by Stripe

While attending Columbia Law School, Ortal served as an intern for the Federal Trade Commission. Prior to joining Goodwin, Ortal was an associate at Erdinast, Ben Nathan, Toledano & Co. in Tel Aviv.